Tuberculosis vaccine hopes fade
A major trial of a new booster vaccine has ended in failure, marking a major setback in the fight against tuberculosis (TB).
It was the first big study in infants since the Bacillus Calmette-Guerin (BCG) vaccine was introduced in 1921.
BCG is only partially effective against the bacterium that causes TB, which is why several international teams are working on new vaccines.
Prof Helen McShane, from the University of Oxford, who developed the vaccine, said that the trial provided valuable information despite the setback.
Read More
Most watched/listened
-
Running barefoot in Wyoming
-
MI5 'approached' Woolwich suspect
-
Saudi drivers in 'sidewalk skiing' craze
-
US road bridge falls into river
-
Witness: 'He pulled a handgun out'
-
Video of Woolwich suspect in 2007
-
Huge fire consumes Rio fuel depot
-
Heathrow: 'Flames were coming out'
-
Bear cub gets stuck in department store
-
Whisky sales fuel copper stills boom
-
Achebe funeral due to take place
-
Family tribute to soldier Lee Rigby
-
April Jones case evidence ends
-
Woolwich victim 'was soldier' - MP
-
Italians mark end of Berlusconi era
~RS~q~RS~~RS~z~RS~31~RS~)
